Wnt5a Signals through DVL1 to Repress Ribosomal DNA Transcription by RNA Polymerase I

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Signaling

Background:

• Ribosome biogenesis is crucial for cell growth and often upregulated in cancer.
• Wnt5a signaling, a non-canonical pathway, has shown tumor-suppressive roles in breast cancer.
• Targeting ribosomal RNA (rRNA) synthesis is a common strategy in cancer therapy.

Purpose of the Study:

• To investigate the mechanism by which Wnt5a suppresses breast cancer cell proliferation.
• To elucidate the role of Wnt5a in regulating ribosomal DNA (rDNA) gene transcription.
• To identify the specific molecular players involved in Wnt5a-mediated suppression of rRNA synthesis.

Main Methods:

• Analysis of Wnt5a's effect on rDNA gene transcription in breast cancer cells.
• Investigation of Dishevelled1 (DVL1) localization and binding to rDNA.
• Assessment of Sirtuin 7 (SIRT7) release from rDNA loci and Pol I transcription machinery disassembly.

Main Results:

• Wnt5a rapidly represses rDNA gene transcription and establishes a repressive chromatin state.
• These effects are dependent on Dishevelled1 (DVL1), which binds to rDNA regions.
• DVL1 binding leads to the release of Sirtuin 7 (SIRT7) and disassembly of the Pol I transcription machinery.

Conclusions:

• Wnt5a signals via DVL1 to suppress rRNA transcription in breast cancer cells.
• This mechanism explains Wnt5a's tumor-suppressive function and the impact of Wnt5a pathway disruption on tumor growth.
• The findings reveal a novel pathway for Wnt5a in controlling ribosome biogenesis and its implications in breast cancer.